Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase I Trial of Berberine in Chinese with Ulcerative Colitis.
Xu L, Zhang Y, Xue X, Liu J, Li ZS, Yang GY, Song Y, Pan Y, Ma Y, Hu S, Wen A, Jia Y, Rodriguez LM, Tull MB, Benante K, Khan SA, Cao Y, Jovanovic B, Richmond E, Umar A, Bergan R, Wu K. Xu L, et al. Among authors: bergan r. Cancer Prev Res (Phila). 2020 Jan;13(1):117-126. doi: 10.1158/1940-6207.CAPR-19-0258. Epub 2019 Oct 16. Cancer Prev Res (Phila). 2020. PMID: 31619442 Clinical Trial.
Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial.
Khan SA, Chatterton RT, Michel N, Bryk M, Lee O, Ivancic D, Heinz R, Zalles CM, Helenowski IB, Jovanovic BD, Franke AA, Bosland MC, Wang J, Hansen NM, Bethke KP, Dew A, Coomes M, Bergan RC. Khan SA, et al. Among authors: bergan rc. Cancer Prev Res (Phila). 2012 Feb;5(2):309-19. doi: 10.1158/1940-6207.CAPR-11-0251. Cancer Prev Res (Phila). 2012. PMID: 22307566 Free PMC article. Clinical Trial.
A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast.
Lee O, Page K, Ivancic D, Helenowski I, Parini V, Sullivan ME, Margenthaler JA, Chatterton RT Jr, Jovanovic B, Dunn BK, Heckman-Stoddard BM, Foster K, Muzzio M, Shklovskaya J, Skripkauskas S, Kulesza P, Green D, Hansen NM, Bethke KP, Jeruss JS, Bergan R, Khan SA. Lee O, et al. Among authors: bergan r. Clin Cancer Res. 2014 Jul 15;20(14):3672-82. doi: 10.1158/1078-0432.CCR-13-3045. Clin Cancer Res. 2014. PMID: 25028506 Free PMC article. Clinical Trial.
Prevention of colonic neoplasia with polyethylene glycol: A short term randomized placebo-controlled double-blinded trial.
Wali RK, Bianchi L, Kupfer S, De La Cruz M, Jovanovic B, Weber C, Goldberg MJ, Rodriguez LM, Bergan R, Rubin D, Tull MB, Richmond E, Parker B, Khan S, Roy HK. Wali RK, et al. Among authors: bergan r. PLoS One. 2018 Apr 4;13(4):e0193544. doi: 10.1371/journal.pone.0193544. eCollection 2018. PLoS One. 2018. PMID: 29617381 Free PMC article. Clinical Trial.
Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin.
Roy HK, Turzhitsky V, Wali R, Radosevich AJ, Jovanovic B, Della'Zanna G, Umar A, Rubin DT, Goldberg MJ, Bianchi L, De La Cruz M, Bogojevic A, Helenowski IB, Rodriguez L, Chatterton R, Skripkauskas S, Page K, Weber CR, Huang X, Richmond E, Bergan RC, Backman V. Roy HK, et al. Among authors: bergan rc. Gut. 2017 Feb;66(2):285-292. doi: 10.1136/gutjnl-2015-309996. Epub 2015 Oct 26. Gut. 2017. PMID: 26503631 Free PMC article. Clinical Trial.
Some aspects of analysis of gene array data.
Jovanovic BD, Bergan RC, Kibbe WA. Jovanovic BD, et al. Cancer Treat Res. 2002;113:71-89. doi: 10.1007/978-1-4757-3571-0_5. Cancer Treat Res. 2002. PMID: 12613351 Review. No abstract available.
Genistein treatment duration effects biomarkers of cell motility in human prostate.
Zhang H, Gordon R, Li W, Yang X, Pattanayak A, Fowler G, Zhang L, Catalona WJ, Ding Y, Xu L, Huang X, Jovanovic B, Kelly DL, Jiang H, Bergan R. Zhang H, et al. Among authors: bergan r. PLoS One. 2019 Mar 27;14(3):e0214078. doi: 10.1371/journal.pone.0214078. eCollection 2019. PLoS One. 2019. PMID: 30917169 Free PMC article. Clinical Trial.
Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer.
Takimoto CH, Glover K, Huang X, Hayes SA, Gallot L, Quinn M, Jovanovic BD, Shapiro A, Hernandez L, Goetz A, Llorens V, Lieberman R, Crowell JA, Poisson BA, Bergan RC. Takimoto CH, et al. Among authors: bergan rc. Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1213-21. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14652284 Clinical Trial.
121 results